Mitchell J Giangobbe MD, RVT, FACS is categorized under Surgeons in Sun City West, AZ and active since 1990.
Mitchell J Giangobbe MD, RVT, FACS was established in 1990, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number by the NAICS.
If you are seeking more information, feel free to contact Mitchell Giangobbe at the company’s single location by writing to 13629 W Camino Del Sol # 180, Sun City West, Arizona AZ 85375 or by phoning (623) 584-7874. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mitchell J Giangobbe MD, RVT, FACS |
| Contact Person: | Mitchell Giangobbe |
| Address: | 13629 W Camino Del Sol # 180, Sun City West, Arizona 85375 |
| Phone Number: | (623) 584-7874 |
| Website Address: | veincarearizona.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1990 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Surgeons |
| Share This Business: |
Mitchell J Giangobbe MD, RVT, FACS was started in 1990 to provide professional Surgeons under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mitchell Giangobbe for inquiries that concern Mitchell J Giangobbe MD, RVT, FACS by calling the company number (623) 584-7874, as your correspondence is most welcome. Additionally, the physical location of the single location of Mitchell J Giangobbe MD, RVT, FACS can be found at the coordinates 33.65436,-112.35691 as well as the street address 13629 W Camino Del Sol # 180 in Sun City West, Arizona 85375.
For its online presence, you may visit Mitchell J Giangobbe MD, RVT, FACS’s website at veincarearizona.com and engage with its social media outlets through on Twitter and on Facebook.